(Q62813977)
Statements
VISIONARY-MS (English)
0 references
A Phase 2, Randomized, DB-PC, Parallel Group Study for the Treatment of Visual Pathway Deficits In Chronic Optic Neuropathy to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of CNM-Au8 For Remyelination In Multiple Sclerosis (English)
0 references
23 November 2018
0 references
30 December 2019
0 references
150
0 references
18 year
0 references
50 year
0 references